Evidence map›Paper›PMID 20506533›Full record

ArticleStem cells (Dayton, Ohio)2010

Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.

Randolph S Faustino, Anca Chiriac, Nicolas J Niederlander, Timothy J Nelson, Atta Behfar, Prasanna K Mishra, Slobodan Macura, Marek Michalak, Andre Terzic, Carmen Perez-Terzic

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Systems proteomics for translational network medicine.Circulation. Cardiovascular genetics · 2012
    Article
  14. Energy metabolism in nuclear reprogramming.Biomarkers in medicine · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Randolph S FaustinoMarriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota 55905, USA.
Anca Chiriac
Nicolas J Niederlander
Timothy J Nelson
Atta Behfar
Prasanna K Mishra
Slobodan Macura
Marek Michalak
Andre Terzic
Carmen Perez-Terzic
Mayo Clinic · USUniversity of Alberta · CA

Funding

CARDIOVASOLOGYT32HL007111 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug · 1985 to 2026
$8.7M
Regulation of cardiac nuclear pore structure and functionR01HL085208 · NHLBI · MAYO CLINIC ROCHESTER · PI TERZIC, CARMEN MILITZA · 2007 to 2011
$1.9M
Cardioprotective Repair through CardiopoiesisR01HL083439 · NHLBI · MAYO CLINIC ROCHESTER · PI TERZIC, ANDRE · 2006 to 2010
$1.8M
CIHR MOP-53050NHLBI NIH HHS HL07111NHLBI NIH HHS HL83439NHLBI NIH HHS HL85208NHLBI NIH HHS R01 HL083439NHLBI NIH HHS R01 HL085208NHLBI NIH HHS T32 HL007111
6 · The paper itself

Abstract

Genomic perturbations that challenge normal signaling at the pluripotent stage may trigger unforeseen ontogenic aberrancies. Anticipatory systems biology identification of transcriptome landscapes that underlie latent phenotypes would offer molecular diagnosis before the onset of symptoms. The purpose of this study was to assess the impact of calreticulin-deficient embryonic stem cell transcriptomes on molecular functions and physiological systems. Bioinformatic surveillance of calreticulin-null stem cells, a monogenic insult model, diagnosed a disruption in transcriptome dynamics, which re-prioritized essential cellular functions. Calreticulin-calibrated signaling axes were uncovered, and network-wide cartography of undifferentiated stem cell transcripts suggested cardiac manifestations. Calreticulin-deficient stem cell-derived cardiac cells verified disorganized sarcomerogenesis, mitochondrial paucity, and cytoarchitectural aberrations to validate calreticulin-dependent network forecasts. Furthermore, magnetic resonance imaging and histopathology detected a ventricular septal defect, revealing organogenic manifestation of calreticulin deletion. Thus, bioinformatic deciphering of a primordial calreticulin-deficient transcriptome decoded at the pluripotent stem cell stage a reconfigured multifunctional molecular registry to anticipate predifferentiation susceptibility toward abnormal cardiophenotype.

Indexed as

AnimalsCalreticulinCell DeathCell DifferentiationCells, CulturedEmbryo, MammalianEmbryonic Stem CellsGene Expression ProfilingMiceMice, KnockoutMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionMyocardiumPhenotypeCalreticulin

Identifiers

PMID20506533
PMCPMC3129684
OpenAlexW2085316849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.